Aiforia - Medical Image Analysis Software

Five years ago, at the time of the IPO, the targets were tough. According to them, the company would now be cash flow positive (by 2025) and revenue would exceed 100 million euros, if five years is considered the medium term. In H1 2026, revenue collapsed to 753 thousand euros and cash is still being burned at an astounding rate. I would like an analysis from management on what has gone wrong and why we should still believe in the never-ending growth story.

14 Likes